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Effect of host immune status on the spontaneous metastasis
of cloned cell lines of the 13762NF rat mammary
adenocarcinoma
S.M. North & G.L. Nicolson
Department of Tumor Biology, The University of Texas M.D. Anderson Hospital and Tumor Institute at
Houston, Houston, Texas 77030, USA.
Summary The importance of host immune status on the spontaneous metastasis of cloned cell lines of the
13762NF rat mammary adenocarcinoma was examined. Cell lines MTLn3 (high metastatic potential), MTF7
and MTLn2 (intermediate metastatic potential) and MTC (low metastatic potential) were subjected to a series
of in vivo assays designed to assess how manipulation of the immune system in the syngeneic F344 host would
affect the ability of these cells to metastasise. Treatment of tumour bearing rats with the immunosuppressive
agents cyclosporin A or cyclophosphamide had little influence on metastasis in this system. Growth of
tumours in congenitally athymic nude rats resulted in reduction of observed metastases. In addition, humoral
immune response was not detectable during a 23-day period of tumour growth in F344 rats. Excision of the
tumour growing in situ reduced the number of metastases when the tumours were resected early (< 10 days),
but at later times tumour resection did not influence the incidence of metastasis. The importance of initial
lymphatic rather than haematogenous routes of dissemination was confirmed in experiments where the
draining inguinal and axillary lymph nodes were removed at different times either before, or after,
subcutaneous mammary fat pad injection of metastatic tumour cells.
The significance of host immune response to a
growing and disseminating neoplasm is actively
debated. Over the last several years there has been
an accumulation of data on numerous tumour
models with respect to immune parameters such as
cytolysis and/or cytostasis by activated
macrophages (Shin et al., 1976; Haskill et al., 1979;
Mantovani et al., 1979; Reading et al., 1983), NK
cells (Herberman et al., 1975; Stutman et al., 1980;
Hanna, 1982), T-lymphocytes (Fogel et al., 1979;
Schirrmacher et al., 1979), and humoral antibodies
(Vaage, 1973; Robins & Baddwin, 1974; Dean et al.,
1982). The majority of the earlier studies were
conducted using highly immunogenic, chemically-
induced tumours of rodents, and the relevance of
these data to human cancer metastasis has been
questioned (Alexander, 1977). Recently, attempts
have been made to develop animal models that
more closely mimic the pathogenesis of cancer
metastasis in humans (Nicolson & Poste, 1982).
One such model developed for studying breast
cancer metastasis is the 13762NF rat mammary
adenocarcinoma (Neri et al., 1982). A number of
cloned cell lines were derived from this tumour
growing s.c. in the mammary fat pad of syngeneic
Fischer F344 rats, and from their spontaneous
metastases (Neri et al., 1982). These cloned cell
lines have subsequently been characterized and
shown to have interrelated metastatic and cell
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surface properties (Welch et al., 1983; Steck &
Nicolson, 1984).
The objective of our study was to examine the
influence of the host on the spontaneous metastasis
of the cloned 13762NF cell lines in syngeneic,
immunocompetent and immune-deprived animals.
We examined: (i) macrophage activation and
infiltration of tumours; (ii) elicitation of humoral
responses during tumour growth; (iii) the effect of
primary tumour excision on metastatic spread; (iv)
the influence of lymphadenectomy on the pattern of
overt metastases; (v) the effect of immuno-
suppressive drugs, such as cyclophosphamide (Cy)
(Freireich et al., 1966) and cyclosporin A (CyA)
(Dreyfuss et al., 1976) on growth and metastasis;
and (vi) the ability of the tumours to metastasise
when transplanted into congenitally athymic nude
rats (Festing et al., 1978). It is apparent from
our data that gross manipulation of the host
immune system has little influence on 13762NF
tumour dissemination; however, these data do indi-
cate that there are immunological responses to
growing 13762NF tumours that may enhance
metastasis of some of the cell lines examined.
Materials and methods
Animals
Inbred 8 week old, virus-free, barrier raised female
Fischer (F344/CDL) rats (RT1 ) were supplied by
the Charles River Breeding Laboratories (Kingston,
NY, USA). Animals were quarantined for 7 days
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before use and fed standard rodent chow and
unchlorinated spring water ad libitum. Congenitally
athymic 8 week old nude rats (Rowett/PVG, RT1C)
were supplied from the SPF facility at UT M.D.
Anderson Hospital and Tumor Institute. All
animals were maintained under pathogen-free
conditions as set forth by The University of Texas
System Cancer Center and the Institute of
Laboratory Animals Resources, United States
National Research Council.
Cell lines
Cloned sublines of the 13762NF rat mammary
adenocarcinoma (MTLn3, MTLn2, MTF7 and
MTC) were obtained and grown as previously
described (Neri et al., 1982). All cell lines used were
screened routinely for contamination and found to
be free ofmycoplasma and virus.
In vivo assays
Spontaneous metastasis assays were carried out as
described previously (Neri et al., 1982). Single cell
suspensions of tumour cells were prepared after
removal of the cells for 100 mm tissue culture plates
(Corning Glass, Corning, NY) with 0.25% trypsin
(GIBCO, Grand Island, NY) in Dulbecco's PBS
(DPBS). The cells were washed twice in alpha-
modified Eagles medium (AMEM), and 1 x 106
tumour cells were injected s.c. into the mammary
fat pad of rats anaesthetized with methoxyflurane
(Metofane; Pitman-Moore, Inc., Washington
Crossing, NJ, USA). The rats were killed by
inhalation of Metofane 23 or 30 days after injection
of tumour cells, and they were then scored for
overt metastases. Surgical resection of the tumours
growing s.c. and lymphadenectomy were carried out
on animals anaesthetized with Metofane. After
tumour resection the animals were kept for up to 3
months before they were killed and examined for
metastases.
Winn-type assay
Bacillus Calmette-Guerin (Trudeau Institute, Saranac
Lake, NY) activated macrophages were elicited in
the peritoneal cavity of Fischer F344 rats by i.p.
injection of 5 x 107 plaque-forming units (pfu) per
rat. After 21 days the animals were rechallenged i.p.
with 107 pfu/rat. Four days later the peritoneal
cavity was lavaged with 20ml DPBS. Macrophage
populations were further activated vitro with
50ngml-1 lipopolysaccharide before reinjection.
The ratios used were 1:10, 1:1 and 5:1
macrophages to tumour cells.
Immunosuppressive drugs
CyA (Sandoz AG, Basel, Switzerland) was
administered daily at a dose of 20mgkg- by
stomach intubation. Cy (Cytoxan; Mead Johnson,
Evansville, IN) was administered i.p. at a dose of
20mgkg 1 three days before challenge with tumour
cells.
Histology
Tissues were prepared for histological analysis by
fixation in 10% neutral formalin, dehydration,
paraffin embedding and sectioning. Sections 5pm
thick were stained with haematoxylin and eosin.
Detection ofserum antibodies
An 0.8ml sample of blood/rat was taken from the
jugular vein of tumour bearing rats at regular
intervals during growth of the s.c. tumour. Serum
samples were stored at -20°C until required. The
presence of specific antibodies in the serum was
determined directly with an antiglobulin-binding
assay described previously (Hall et al., 1979).
Tumour cells (MTLn3, MTF7, etc.) were grown as
monolayers in 96-well microtest plates (Corning)
containing AMEM and 10% foetal bovine serum.
The cell monolayers were exposed for 1 h to
dilutions of antisera, washed twice and incubated in
fresh medium at 0°C for 30min. After a further
wash, cell bound antibodies were determined by
incubation with 1251-labelled sheep/rat F(ab')2, (a
generous gift of Dr C.J. Dean, Institute of Cancer
Research, Sutton, Surrey, UK). The amount of
specific antibody bound was determined by
subtracting radioactivity bound by cells treated with
normal sera from radioactivity bound by cells
treated with immune sera.
Determination ofFc receptor-positive cells
Analysis of Fc receptor-positive (FcR+) cells is
described in detail elsewhere (North & Nicolson,
1985). In brief, tumour-bearing (23 or 30 days
tumour growth) animals were killed, and the
tumours removed aseptically. Antibody-coated
sheep red blood cells (EAs) were prepared by
incubating rat anti-sheep red blood cell (SRBC)
serum (heat-inactivated at 56°C for 45min) with a
freshly prepared 4% suspension of SRBC in
AMEM at a final dilution of 1:20. After being
mixed for 1 h at room temperature, the EAs were
washed 3 times with AMEM and stored overnight
at 40C. One ml of the EA suspension was
transferred to a polypropylene centrifuge tube
containing 1 ml of a tumour cell suspension
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centrifuged for 5min at 250g. The pellet was gently
resuspended in 5ml of medium, and the number of
FcR+ cells was determined. A cell was considered
FcR+ if 4 or more SRBCs were associated with in
the form of a rosette.
Results
Influence ofactivated macrophages on tumour
growth and dissemination
The clonal lines of the 13762NF mammary
adenocarcinoma show differences in their
spontaneous metastatic potentials. Of these lines,
MTLn3 cells are the most metastatic (Neri et al.,
1982). In order to examine the effect of activated
macrophages on metastasis in this sytem, MTLn3
cells were mixed with macrophages at ratios of
1:10; 1: 1; and 5: 1 (macrophages:tumour cells) and
then were injected s.c. into the mammary fat pad of
F344 rats. Our previous data (North & Nicolson,
1985) had shown that MTLn3 tumours growing in
situ had 20% FcR+ cells. The ratios of activated
macrophages to tumour cells used in these assays
were consequently kept similar to that found in
vivo. The data in Table I indicate that co-injection
of activated macrophages with the tumour cells did
not influence tumour growth. At 23 days after
injection of tumour cells the animals were examined
for the presence of overt metastases, and differences
in the pattern of lung and lymph node metastasis
relative to the ratio of input macrophages were not
observed (Table I).
Analysis oftumour bearing serumfor the presence of
antibodies
Previous work with certain tumours has shown that
syngeneic tumour bearing animals produce
detectable amounts of serum antibody with
specificity for the immunising tumour (Dean et al.,
1982). We wished to determine whether or not it
was possible to detect serum antibodies to sublines
of the 13762NF adenocarcinoma, and if the
differences in spontaneous metastatic potential
characteristic of these sublines influenced the ability
of the host to mount a detectable humoral
response. To carry out this study, blood samples
were removed from the jugular veins of syngeneic
rats 24h prior to injection s.c. of either MTLn3
cells (high metastatic potential), MTF7 cells
(intermediate metastatic potential) or MTC cells
(low metastatic potential), as described in Materials
and methods. Blood samples were taken at regular
intervals during a 23-day assay period, and the
presence of specific serum antibodies against
tumour cells was quantitated by using an
antiglobulin binding assay with cells similar to the
immunising tumour to detect specific cell-bound
antibodies. Using this assay we were unable to
detect significant amounts of serum antibodies to
the MTF7 and MTC tumour cell lines (Figure 1). It
should be emphasized that, for each tumour, the
data shown in Figure 1 represent pooled serum
samples from a total of 9 rats. Within this group
there was a degree of individual heterogeneity in
response to the MTLn3 tumour which gave values
of from 500 to 900cpm over the assay period of 23
days. An equivalent variation was not seen with
either MTF7 or MTC tumours. Because of this
variation, it is conceivable that some of the animals
may be mounting a minor humoral response to the
MTLn3 tumour, but this was not a consistent
result. Failure to detect such antibodies in the
serum does not eliminate the possibility that a
humoral response to the tumour occurred, because
antibody may have been complexed with antigen
and rapidly removed from circulation.
Effect ofexcision ofthe tumour on metastasis
It is possible that the increased tumour burden that
results from the continued presence of an s.c.
Table I Effect ofactivated macrophages on the growth and metastasis of MTLn3 cells
Metastases (no ofrats with metastases/no. ofrats)a
Ratio of
macrophages to Average tumour Inguinal Axillary Lumbar Renal
Tumour tumour cells diameter (mm) Lung nodes nodes nodes nodes
MTLn3(T18) 0 10.67+2.84b 3/6 4/6 1/6 1/6 0/6
MTLn3(T18) 1:10 13.37+3.05 0/6 5/6 3/6 2/6 0/6
MTLn3(T19) 0 13.75+1.49 3/6 2/6 3/6 0/6 0/6
MTLn3(T19) 1:1 13.16+1.80 3/6 4/6 3/6 0/6 0/6
MTLn3(T19) 5:1 14.92+2.28 2/6 5/6 3/6 1/6 0/6
Abbreviations: T, number of passages in vitro. aThe data illustrate one representative experiment. bStandard
deviation.
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Figure 1 Examination of tumour-bearing serum for
specific antibodies. The assays were performed on
confluent monolayers of MTLn3 (l), MTF7 (l) and
MTC (A) cells, using 125I-labelled sheep/rat F(ab)2.
All serum samples were assayed in triplicate at a
dilution 1: 10. For a positive control Sprague
Dawley/Fischer 344 rat (RTlV/RTl 1) antisera, was
used at a 1:10 dilution ( 9500cpm).
tumour implant adversely influences the ability of
the host to eradicate micrometastases. Therefore,
the effect of surgical resection on metastasis was
examined using MTLn3, MTF7, and MTC cells.
Surgical resections of the s.c. tumours were carried
out at different times over a 23-day period; after
resection the animals were kept for period of up to
3 months. When the s.c. tumour was MTF7 and
the tumours were removed early (<10 days of
growth), all animals were free of overt metastases
for up to 3 months. Animals bearing tumours which
were excised at later times (around 15 days) were
more heterogeneous in their metastatic involvement,
in that some animals in each group had metastatic
lesions, while others in the group did not. In no
instance did all of the rats develop metastasis in
this experiment. This result was apparent even with
the highly metastatic MTLn3 tumours; in this case,
many of the animals remained disease free at the
end of the observation period, provided that the
draining inguinal lymph node was removed at the
time of early tumour resection (Table II). This
absence of metastatic disease was not the case when
the MTLn3 tumour was left in situ; in this
experiment all of the animals had lymph node
metastases and -40-50% had lung metastases at 30
days. These results indicate that the host immune
system is able to successfully eradicate or suppress
the growth of metastases in the absence of
substantial tumour burden, because by 5 days after
injection MTLn3 cells had metastasised beyond the
draining lymph node (see below).
The route ofmetastasis
Human breast cancers almost always spread first by
the lymphatics, and then haematogenously when
they colonize the lung, bone, liver and brain
(Gilbert & Kagan, 1976). To confirm the impor-
tance of the draining inguinal and axillary lymph
nodes to the metastatic process in this sytem, we
surgically removed the lymph nodes from rats 1 or
5 days before s.c. injection of MTLn3 cells or 5, 10
or 15 days after s.c. injection of tumour cells.
Control groups were subjected to sham surgery.
Table II Effect of tumour excision on spontaneous metastasis of 13762NF cell clones
Metastases (no. rats with metastases/no. ofrats)
Time of
resection Inguinal Axillary Lumber
Tumour (days) Lung nodes nodes nodes Other (Location)
MTF7(T17) NE 0/10 0/10 0/10 0/10 0/10
8 0/6 0/6 0/6 0/6 0/6
10 1/6 0/6 0/6 0/6 0/6
15 2/16 0/16 0/16 0/16 0/16
MTC(T12) NE 0/10 0/10 0/10 0/10 0/10
15 3/20 0/20 0/20 0/20 0/20
MTLn3(T18) NE 4/10 6/10 7/10 6/10 1/10 (renal)
9 5/8 R 1/8 4/8 1/8 (renal)
2/8 (thymus)
15 1/8 R 4/8 1/8 1/8 (mesentery)
20 2/7 R 2/7 3/7 1/7 (renal)
Abbreviations: T, number of passages in vitro; NE, not excised; R, resected with sc tumour. After tumour
resection, animals were kept for periods of up to 3 months. Animals with tumours not resected were killed at
30 days of tumour growth.
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At 15 days after injection of tumour cells, many
of the animals had macroscopic lymph node
tumours. Removal of both the inguinal and axillary
lymph nodes before s.c. injection of tumour cells
produced a significant (P<0.001) effect on the
metastasis of MTLn3 cells (Table III). When the
lymph nodes were removed 5 days before s.c.
tumour cell injection only 20% of the animals
developed metastases; in these animals with
metastasis there was extensive tumour involvement
in both the lung and remaining lymph nodes (Table
III). Removal of the lymph nodes 1 day before s.c.
injection of tumour cells also reduced the
percentage of animals with metastases.
tumour involvement, including the contralateral
nodes. By 15 days post injection
- 60% of the
animals in both groups had lung metastases, and
there was no consistent difference in the pattern of
lymph node tumour involvement (Table III).
Effect ofimmunosuppressive drugs on spontaneous
metastasis
The administration of the immunosuppressive drug
CyA has been reported to increase the metastatic
potential of a number of immunogenic rat and
mouse fibrosarcomas (Eccles et al., 1980). To test
the effect of this drug on 13762NF adenocarcinoma
Table III Effect oflymphadenectomy on the spontaneous metastasis of MTLn3 (T18) cells
Metastases (no. rats with metastases/no. ofrats) Time of Average
treatment tumour Inguinal Axillary Lumbar Renal
(days) diameter (mm) Lung nodes nodes nodes nodes Other (Location)
-5 sham 13.45+3.40a 6/gb 9/9 4/9 5/9 0/9 0/9 -5 13.33+3.48 2/lOC R R 2/10 2/10 1/10 (thymus)
1/10 (mesentery)
1/10 (cervical)
2/10 (sub-axillary) -1 sham 21.44+4.17 4/9 5/9 6/9 1/9 0/9 0/9 -1 22.50+3.85 2/9 R R(1/9) 0/9 0/9 0/9 +5 sham 21.72+4.42 4/9 9/9 8/9 6/9 3/9 3/9 (thymus)
(1/9) (2/9) (2/9) (1/9) 1/9 (mesentery)
2/9 (cervical)
2/9 (illiac) +5 23.80+6.11 5/9 R(1/9) R(1/9) 3/9 0/9 0/9 + 10 sham 24.38+4.16 4/8 8/8 7/8 3/8(1/8) 2/8 0/8 +10 21.06+5.35 2/9 R(3/9) R(4/9) 191/(1/9) 0/9 1/9 (sub-axillary) +15 sham 23.50+4.36 3/6 5/6 4/6 2/6 0/6 1/6 (mesentery)
(1/6) (1/6) (1/6) +15 20.70+3.47 3/5 R(1/5) 2/5(2/5) 0/5 0/5
Abbreviations: R, lymph nodes removed. aStandard deviation. bSignificance (P<0.001) between control and experimental groups determined by one way analysis of variance. CAll metastases from the same two animals. ( )Lymph node metastases on the contralateral side.
The effect of lymphadenectomy on metastasis
after injection of MTLn3 cells was less clear. At as
early as 5 days after injection of tumour cells,
metastasis occurred beyond the draining lymph
nodes; this occurrence was particularly striking
when the contralateral nodes showed gross tumour
involvement, a situation not usually seen in the
usual 23- or 30-day metastasis assays. It is also
apparent from these data that surgical trauma
profoundly influences the development of
metastases. This relationship was most obvious
when surgery was performed 5 days after s.c.
injection of tumour cells, because most of the
sham-treated animals had extensive lymph node
metastasis we selected three cell lines: MTLn3,
MTLn2 and MTF7. In addition, the chemo-
therapeutic drug Cy was also evaluated in
combination with CyA in a 30-day assay. Highly
metastatic MTLn3 tumours were unaffected by the
administration of these drugs either alone or
together (Table IV). MTLn2 and MTF7 tumours of
intermediate metastatic potential also did not show
consistent increases in metastasis in drug-treated
animals. However, there was a decrease (usually
50%) in the number of FcR+ cells that had
infiltrated the tumours (Table IV). Neither drug
influenced the overall growth rates of the MTLn3
and MTF7 tumours at s.c. sites (Figure 2). The752 S.M. NORTH & G.L. NICOLSON
Table IV Immunosuppression and spontaneous metastasis of 1376NF cell clones
Metastases (rats with metastases/total rats)
% FcR+ Inguinal Axillary Lumbar Renal
Tumour Treatment cells Lung nodes nodes nodes nodes Other
MTLn3(T18) control 16.0 5/6 5/6 4/6 0/6 1/6 0/6
Cy 8.08 5/6 6/6 5/6 3/6 1/6 0/6
Cy and CyA 8.08 6/6 5/6 6/6 4/6 3/6 1/6 (il)
CyA 5.Oa 6/6 5/6 6/6 3/6 1/6 0/6
MTLn2(T40) control 10.0 0/6 0/6 0/6 0/6 0/6 0/6
Cy 5.08 0/6 1/6 1/6 0/6 0/6 0/6
Cy and CyA 6.0a 2/6 1/6 1/6 1/6 1/6 1/6 (il)
CyA 3.0a 0/6 1/6 0/6 0/6 0/6 0/6
MTF7(T18) control NT 0/6 0/6 0/6 0/6 0/6 0/6
Cy NT 0/6 1/6 0/6 0/6 0/6 0/6
Cy and CyA NT 0/6 1/6 1/6 0/6 0/6 0/6
CyA NT 0/6 1/6 1/6 0/6 0/6 0/6
Abbreviations: T, passage number in vitro; FcR+, FC-receptor-positive, Cy, cyclophosphamide; CyA, cyclosporin A; NT, not
tested; il, iliac. Cy 20mgkg1 i.p. day-3. CyA 20mgkg-1 daily from day-l. 8Significance (P<0.001) between untreated and treated
groups determined by one way analysis of variance.
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Figure 2 Growth curves of subclones of the 13762NF adenocarcinoma (see Materials and methods) (a)
MTF7 cells; (b) MTLn2 cells; (c) MTLn3 cells. Control (0); Cy (-); Cy and CyA (A); CyA (V). For MTLn2
cells significance (P<0.001) between control and treated groups at 30 days determined by one way analysis of
variance.
only tumour to show a difference in s.c. growth
rate was the MTLn2 tumour, where animals in the
treated groups had larger tumours at 30 days than
animals in the control group.
Ability ofMTLn3 cells to metastasise in the athymic
nude rat
To assess the ability of 13762NF tumour cells to
metastasise in immune-deprived animals, a
spontaneous metastasis assay was performed using
congenitally athymic nude rats (PVG/RT1C). After
30 days tumour growth the animals were killed and
examined macro- and microscopically for
metastases to lung and to lymph nodes. None of
the nude rats had metastases, while the control
group of age- and sex-matched immunocompetent
F344 rats had the usual pattern of lung and lymph
node metastases. No significant differences in the
growth rates of the tumours in either host was
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observed. However, we did note that the percentage
of FcR+ cells infiltrating MTLn3 tumours growing
in the nude rats was lower (10% FcR+ cells) than
in F344 rats (18% FcR+ cells) (Table V).
Discussion
Our studies confirm the importance of the
lymphatics in the dissemination of metastatic rat
mammary tumour cells. The 13762NF rat
mammary adenocarcinoma metastasizes in a
manner analogous to human breast cancer, that is,
via lymphatic spread to the regional lymph nodes,
followed by blood-borne tumour spread to major
organs such as the lung. These data, and the
capability of this tumour to colonize to bone and
brain (Steck, North and Nicolson, unpublished
data), in addition to lung and lymph nodes, further
establishes the relevance of the 13762NF
adenocarcinoma as a model for human breast
cancer metastasis.
Our failure to detect specific serum antibodies to
MTLn3, MTF7 or MTC cells in tumour-bearing
animals does not exclude the possibility that a
humoral immune response was elicited against the
tumour cells (North et al., 1982). The ability to
generate monoclonal antibodies to tumour-
associated antigens by using MTLn3 tumour-
bearers as a source of spleen cell donors confirms
this assumption (North et al., 1985). However, it is
likely that serum antibodies are immediately
complexed with antigen and rapidly removed from
circulation, rendering them undetectable in the
assay used here.
Other experiments to test the possible role of
host mechanisms (such as immune suppression) in
interfering with metastasis were inconclusive.
Originally it was thought that the effects of CyA
were restricted to suppression of T lymphocytes
(Borel et al., 1977). Recent reports have now
established that the influence of CyA on the
immune system is much more extensive (Kunkel &
Klaus, 1980; Klaus, 1981). Our data showed that at
Table V Spontaneous metastasis of MTLn3(T18) cells in athymic nude rats
Metastases (rats with metastases/total rats)
Local tumour
Average tumour % FcR+ Inguinal Axillary Lumbar Renal
Host diameter (mm) cells Lung nodes nodes nodes nodes
F344 17.33+2.42a 18.70 3/9 8/9 5/9 6/9 2/9
PVG nudes 14.25+2.02 10.80 0/8 0/8 0/8 0/8 0/8
aStandard deviation.
We studied the interactions that occur in vivo
between the host and the 13762NF tumour. We
found that, when animals were subjected to surgical
trauma after s.c. injection of tumour cells extensive
metastases occurred throughout the lymphatics,
including lymph node sites not usually involved. In
all cases the extent of metastatic spread was a
reflection of the time of surgery relative to injection
of tumour cells, with the maximum effect at 5 days
after injection. Metastasis beyond the draining
inguinal lymph nodes must, therefore, have
occurred before day 5 to involve the contralateral
nodes. Early removal of tumour growing s.c. also
influenced the developed of macroscopic metastases,
and the majority of the animals at 3 months were
still free of disease. These data suggest that while
there may be an active immune response to the
MTLn3 cells, in the presence of a growing s.c.
tumour it is insufficient to control the development
of overt metastases.
the dose used (20mgkg-1 orally once a day) CyA
did not influence significantly the dissemination of
MTLn3, MTLn2 or MTF7 cells in spontaneous
metastasis assays. It should be noted that in this
case the assay period was relatively short (30 days)
and the tumour remained in situ. The possibility
remains that removal of the tumour combined with
a more extensive observation period could have
resulted in subsequent metastases, as has been
reported by other investigators (Eccles et al., 1980).
Using this assay, the only obvious effect of CyA
was a reduction in the number of FcR+ cells
infiltrating the tumour. Similar observations have
been made by Eccles et al. (1980), who used both
mouse and rat fibrosarcomas.
Another approach to testing the influence of T
cell immunity in this system has been to grow the
tumours in congenitally athymic nude rats (Eccles
et al., 1979). One potential problem with this
approach, however, is that the nude rats used were754 S.M. NORTH & G.L. NICOLSON
histoincompatible with Fischer F344 rats, and
recent reports have indicated that Rowett nude rats
possess some residual T cell activity that may be
sufficient for mounting a weak allo-response to the
13762NF tumour. It is interesting that no
metastases were observed when MTLn3 cells were
growing in nude rats, while age-matched
immunocompetent controls had the usual pattern
of lung and lymph node metastasis. From these
data it is conceivable that T cell-mediated immunity
is important in enhancing the spontaneous
metastasis in this system.
Although the effects of CyA on the immune
system are known to be extensive (Shevach, 1985),
recent reports have suggested that there are
pathways of lymphocyte activation which are
resistant to CyA. Therefore, the effect of CyA on
the spontaneous metastasis of MTLn3 cells, and the
results obtained from congenitally athymic nude
rats, suggest that whatever effect T cell-mediated
immunity has on spontaneous metastasis in this
system, it is apparent only in T cell deprived
animals. The lack of spontaneous metastases seen
when the highly metastatic MTLn3 tumour cells are
grown in nude rats suggest that either these cells
are susceptible to an NK mediated cytolytic
mechanism, or that in the immunocompetent host a
T cell-mediated immune response may be elicited
which enhances the metastatic capability of these
cells, conceivably by the induction of T suppressor
cells.
All the experiments described in this
communication used tumour cells inoculated
directly from tissue culture. Thus it cannot be ruled
out that these tumour cell lines behave differently if
subsequently passaged in vivo and then reassayed.
Woodruff and Hodson (1985), among others, have
demonstrated that this is indeed the case with some
tumours. We have also shown in a previous
communication that after one passage in vivo the
clonal sublines of the 13762NF rat mammary
adenocarcinoma show differences in their
susceptibility to macrophage-mediated cytolysis
(North & Nicolson, 1985).
In conclusion, the results of this study confirm
the importance of the lymphatics in the
dissemination of the rat 13762NF adenocarcinoma.
Our data demonstrate that gross manipulation of
the host immune system by the use of immuno-
suppressive drugs has little influence on metastatic
spread. However, more subtle immunological
responses may be involved, as seen by the influence
of tumour burden and time of tumour excision on
the development of overt metastases. Our inability
to substantially influence the pattern of metastasis
by a variety of experimental manipulations shows
that irrespective of their metastatic potential these
tumour sublines are not highly immunogenic in the
syngeneic host. These data indicate that along with
the similarities in cell surface molecules (Steck &
Nicolson, 1984), sensitivities to therapeutic agents
(Welch & Nicolson, 1983), and biological properties
(Neri et al., 1982), the 13762NF adenocarcinoma
system shows immunological properties that are
analogous to human breast cancer, such as
immunogenicity and humoral response.
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